What Immunopathogenic Similarities Exist Between SARSCov-2 Infection And Multiple Sclerosis?: A Plea For Daily Vitamin D Supplementation To Improve Quality Of Life! - Abstract
For decades, arguments have been made for vitamin D supplementation as an add-on therapy “for” and “against” for people with multiple sclerosis. The COVID-19 pandemic has challenged therapists to protect high-risk groups, such as people with multiple sclerosis, from further health damage. In addition to the risk factors established in the general population, such as older age, male gender, hypertension, endocrinological and cardiovascular diseases, advanced disability, highly active disease with frequent drug therapies and doctor consultations as well as comorbidities accumulate in MS.
COVID-19 and MS have overlapping clinical and immunopathogenic properties. Due to the immunomodulatory properties of VitD, adjunctive therapy is likely to be consistent when COVID-19 occurs in PwMS.